Harm Reduction Therapeutics is a nonprofit pharmaceutical company advancing harm reduction therapies to promote public health.
Harm Reduction Therapeutics has raised $9.0M in total funding. The most recent round was Grant. The last funding was announced in March 2023.
Harm Reduction Therapeutics's investors include Purdue Pharma.
Harm Reduction Therapeutics is headquartered in Bethesda, United States.
Harm Reduction Therapeutics is a nonprofit pharmaceutical company advancing harm reduction therapies to promote public health.
Harm Reduction Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Harm Reduction Therapeutics — Funding & Investors." VCBacked, March 21, 2023, https://www.vcbacked.co/company/harm-reduction-therapeutics. Accessed November 12, 2026.
VCBacked. (2023). Harm Reduction Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/harm-reduction-therapeutics
{{cite web |title=Harm Reduction Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/harm-reduction-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Harm Reduction Therapeutics? Request a listing update